This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Other. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Innovations of Mina Mekhail in Tissue Regeneration
Introduction
Mina Mekhail is an innovative inventor based in Montréal, CA. He has made significant contributions to the field of tissue regeneration through his research and development of advanced materials. His work focuses on creating effective solutions for medical applications, particularly in drug delivery and tissue engineering.
Latest Patents
Mina Mekhail holds a patent for the "Rapid formation of chitosan sponges using guanosine 5'-diphosphate: injectable scaffolds for tissue regeneration and drug delivery." This patent discloses a novel method of creating Guanosine 5'-Diphosphate (GDP) crosslinked chitosan sponges. These sponges serve as scaffolds for various tissue regeneration applications, including neural, cardiac, cartilage, and bone regeneration. Additionally, the sponge functions as a drug delivery system, enabling localized controlled release of medications, such as anti-cancer drugs directly at tumor sites.
Career Highlights
Throughout his career, Mina Mekhail has demonstrated a commitment to advancing medical technology. His innovative approach to developing chitosan sponges has positioned him as a key figure in the field of tissue engineering. His work not only addresses critical medical challenges but also opens new avenues for research and application in regenerative medicine.
Collaborations
Mina has collaborated with notable professionals in his field, including Guillermina Almazan and Maryam Tabrizian. These collaborations have enhanced the scope and impact of his research, fostering a collaborative environment that encourages innovation and discovery.
Conclusion
Mina Mekhail's contributions to tissue regeneration and drug delivery exemplify the potential of innovative materials in medical applications. His patent on chitosan sponges represents a significant advancement in the field, promising improved outcomes for patients in need of regenerative therapies.